© 2009 by BMJ Publishing Group & British Cardiac Society
Editorial
Endothelial Progenitor Cells -Trick or Treat?
BLT/QMUL, United Kingdom
Correspondence to: Anthony Mathur, Cardiac, Barts and the London NHS Trust, The London Chest Hospital, Bonner Road, London, E2 9JX, United Kingdom; a.mathur{at}qmul.ac.uk
Accepted 17 September 2009
An understanding of endothelial progenitor cell (EPC) biology offers not only the intellectual rewards of understanding vascular repair but the potential to develop new therapeutic approaches that can be applied to coronary intervention. The field of EPC research is however fraught with problems relating to the characterisation of this cell type. This editorial reflect on the paper by Mills et al that adds further controversy to this area.
Relevant Article
- Dissociation of Phenotypic and Functional Endothelial Progenitor Cells in Patients Undergoing Percutaneous Coronary Intervention
- Nicholas L Mills, Olga Tura, Gareth J Padfield, Christopher Millar, Ninian N Lang, David Stirling, Christopher Ludlam, Marc Turner, G Robin Barclay, and David E Newby
Heart 2009 0: hrt.2008.163162v1.[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
